한글목차

세계 홀 슬라이드 이미징(WSI) 시장의 미래는 원격 병리학, 세포 병리학, 면역 조직화학, 혈액 병리학 시장에서의 기회로 인해 유망할 것으로 예측됩니다. 세계 홀슬라이드 이미징 시장은 2025-2031년 연평균 6.5%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 디지털 병리 솔루션의 채택 확대, 신약 개발 연구 활동의 확대, 효율적이고 정확한 진단에 대한 수요 증가 등입니다.

• Lucintel의 예측에 따르면, 기술별로는 스캐너가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 텔레파시학이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

홀 슬라이드 이미징(WSI) 시장의 전략적 성장 기회

홀 슬라이드 이미징(WSI) 시장은 진단 업무와 환자 결과를 크게 향상시킬 수 있는 수많은 전략적 성장 기회를 제공합니다. 기술이 계속 발전하고 의료 요구가 진화하는 가운데, 이해관계자들은 이러한 기회를 활용하여 도달 범위를 확장하고 서비스를 개선할 수 있습니다. 이러한 성장 분야를 식별하고 행동함으로써 급변하는 환경 속에서 지속적인 경쟁 우위를 확보할 수 있습니다.

• 텔레파솔로지(원격 병리 진단) 서비스 확대: 텔레파솔로지 수요 증가는 홀슬라이드 이미징 제공업체에게 원격 진단 역량을 강화하고, 특히 의료 서비스가 부족한 지역에서의 원격 진단 역량을 강화하며, 전문가 진료를 용이하게 하고, 양질의 의료 서비스에 대한 접근성을 향상시킬 수 있는 기회를 제공합니다. 기회를 제공합니다.
• AI 기반 솔루션 개발: AI 기술에 대한 투자를 통해 이미지 분석을 강화하고, 진단 프로세스를 자동화하고, 정확도를 향상시키는 고급 홀 슬라이드 이미징 플랫폼을 개발하여 신뢰할 수 있는 진단 도구에 대한 수요 증가에 부응할 수 있습니다. 수 있습니다.
• 교육기관과의 협력: 대학 및 연구센터와 협력하여 교육 프로그램 및 연구 이니셔티브를 개발함으로써 홀슬라이드 이미징 기술에 정통한 숙련된 인재를 양성하고, 채용을 촉진하며, 임상 현장에서의 효과적인 활용을 보장할 수 있습니다.
• 전자 의료 기록(EHR)과의 통합에 중점을 둔다: 홀 슬라이드 이미징(WSI) 시스템과 EHR의 상호 운용성을 높여 워크플로우를 간소화하고, 데이터 공유를 개선하며, 병리과 의사가 환자의 병력에 즉시 접근할 수 있도록 하여 전체 진단 프로세스를 개선할 수 있습니다.
• 신흥 시장 개척: 신흥 시장으로의 사업 확장은 큰 성장 기회입니다. 이들 지역에서는 의료 인프라가 구축됨에 따라 디지털 병리 솔루션에 대한 수요가 증가하고 있으며, 맞춤형 홀 슬라이드 이미징을 통해 이를 해소할 수 있습니다.

홀 슬라이드 이미징(WSI) 시장에는 혁신을 촉진하고 의료 서비스를 개선할 수 있는 전략적 성장 기회가 풍부합니다. 이해관계자들은 이러한 기회를 활용함으로써 성공의 발판을 마련하고 디지털 파소학의 발전에 의미 있는 기여를 할 수 있습니다.

홀슬라이드 이미징 시장 활성화 요인 및 과제

홀 슬라이드 이미징(WSI) 시장에는 혁신을 촉진하고 의료 서비스를 개선할 수 있는 전략적 성장 기회가 풍부합니다. 이해관계자들은 이러한 기회를 활용함으로써 성공의 발판을 마련하고 디지털 파소학의 발전에 의미 있는 기여를 할 수 있습니다.

전체 홀 슬라이드 이미징(WSI) 시장을 견인하는 요인은 다음과 같습니다.

• 디지털 병리학에 대한 수요 증가: 효율적이고 정확한 진단 도구에 대한 요구가 높아지면서 의료 서비스 제공업체가 환자 결과를 개선하고 워크플로우 프로세스를 간소화하려는 노력으로 WSI의 채택을 촉진하고 있습니다.
• 기술 발전: 고해상도화, 우수한 분석 소프트웨어 등 영상 처리 기술의 끊임없는 발전은 WSI 시스템의 능력을 향상시켜 효과적인 솔루션을 원하는 의료기관에 매력적인 요소로 작용하고 있습니다.
• 규제 당국의 승인 및 지원: FDA(미국 식품의약국) 등 규제 당국의 WSI 기술 승인으로 의료진의 신뢰가 높아지면서 디지털 병리 진단에 대한 투자가 촉진되고 시장 성장이 가속화되고 있습니다.
• 인공지능의 통합: WSI 시스템에 인공지능을 통합하여 보다 빠르고 정확한 영상 분석을 가능하게 하고, 병리과 의사가 정보에 입각한 판단을 내릴 수 있도록 하며, 전반적인 환자 치료를 개선함으로써 진단에 혁명을 일으키고 있습니다.
• 원격 의료의 채택 확대: 원격 의료, 특히 팬데믹 이후 원격 의료에 대한 수용이 확대되면서 원격 병리 솔루션에 대한 수요가 증가하고 있으며, WSI는 원격 진료에 필수적인 도구가 되어 전문가 치료에 대한 접근성을 향상시키고 있습니다.

홀 슬라이드 이미징(WSI) 시장의 과제는 다음과 같습니다.

• 높은 초기 비용: WSI 시스템 도입에 따른 높은 비용은 많은 의료시설, 특히 예산이 한정된 소규모 시설에 큰 장벽이 되어 보급의 걸림돌이 될 수 있습니다.
• 데이터 프라이버시 문제: WSI는 기밀성이 높은 환자 정보의 디지털 저장 및 공유에 의존하기 때문에 데이터 프라이버시 및 보안에 대한 우려가 문제가 될 수 있으며, 환자의 비밀을 보호하기 위한 엄격한 조치가 필요합니다.
• 기존 시스템과의 통합: WSI 기술과 기존 검사실 및 병원 정보 시스템과의 통합은 복잡하며, 원활한 기능을 보장하기 위한 교육 및 리소스 추가가 필요합니다.

홀 슬라이드 이미징(WSI) 시장은 강력한 성장 촉진요인과 과제가 특징입니다. 이러한 과제를 해결하고 촉진요인을 활용함으로써 이해관계자들은 전략을 최적화하고 디지털 병리 솔루션의 성공적인 도입에 기여할 수 있습니다.

목차

제1장 주요 요약

제2장 세계의 홀 슬라이드 이미징(WSI) 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 홀 슬라이드 이미징(WSI) 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 홀 슬라이드 이미징(WSI) 시장 : 기술별
  • 스캐너
  • IT 인프라
  • 뷰어
  • 영상 관리 시스템
• 세계의 홀 슬라이드 이미징(WSI) 시장 : 용도별
  • 원격 병리진단
  • 세포 병리학
  • 면역조직화학
  • 혈액 병리학
  • 기타
• 세계의 홀 슬라이드 이미징(WSI) 시장 : 최종 용도별
  • 학술기관
  • 연구
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 홀 슬라이드 이미징(WSI) 시장 : 지역별
• 북미의 홀 슬라이드 이미징(WSI) 시장
• 유럽의 홀 슬라이드 이미징(WSI) 시장
• 아시아태평양의 홀 슬라이드 이미징(WSI) 시장
• 기타 지역의 홀 슬라이드 이미징(WSI) 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 홀 슬라이드 이미징(WSI) 시장 성장 기회 : 기술별
  • 세계의 홀 슬라이드 이미징(WSI) 시장 성장 기회 : 용도별
  • 세계의 홀 슬라이드 이미징(WSI) 시장 성장 기회 : 최종 용도별
  • 세계의 홀 슬라이드 이미징(WSI) 시장 성장 기회 : 지역별
• 세계의 홀 슬라이드 이미징(WSI) 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 홀 슬라이드 이미징(WSI) 시장 생산능력 확대
  • 세계의 홀 슬라이드 이미징(WSI) 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

영문목차

The future of the global whole slide imaging market looks promising with opportunities in the telepathology, cytopathology, immunohistochemistry, and hematopathology markets. The global whole slide imaging market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology solutions, expanding research activities of drug discovery, and the rising need for efficient and accurate diagnosis.

• Lucintel forecasts that, within the technology category, scanner is expected to witness the highest growth over the forecast period.
• Within the application category, telepathology is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Whole Slide Imaging Market

The whole slide imaging market is evolving rapidly, influenced by technological advancements and changing healthcare needs. As the demand for efficient and accurate diagnostic solutions grows, several trends are shaping the future of whole slide imaging. These trends reflect the integration of artificial intelligence, improved workflow efficiencies, and increased accessibility of digital pathology.

• Integration of Artificial Intelligence: The incorporation of AI algorithms in whole slide imaging is enhancing diagnostic accuracy and speed, enabling pathologists to identify abnormalities more effectively and reducing the potential for human error.
• Cloud-Based Solutions: The shift toward cloud-based storage and analysis is allowing greater data accessibility and collaboration among healthcare professionals, making it easier to share and review slides remotely, thus streamlining workflows.
• Telepathology Adoption: The rise of telepathology is transforming how pathology services are delivered, particularly in remote or underserved areas, facilitating consultations and second opinions through digital slide sharing, which enhances patient care.
• Regulatory Support: Increasing regulatory approvals for whole slide imaging technologies by bodies like the FDA are driving market growth. These approvals foster confidence in digital pathology solutions and encourage healthcare institutions to adopt these innovations.
• Educational Initiatives: Growing emphasis on educational programs and training for pathologists on whole slide imaging technology is crucial. As professionals become more familiar with digital tools, the adoption rate is expected to rise, promoting better diagnostic practices.

The whole slide imaging market is poised for significant advancements driven by these emerging trends. As technology continues to evolve, stakeholders in healthcare are likely to see enhanced diagnostic capabilities and improved patient outcomes, marking a new era in pathology.

Recent Developments in the Whole Slide Imaging Market

The whole slide imaging market is experiencing rapid advancements, driven by technological innovations, regulatory changes, and increased adoption in clinical settings. These developments are reshaping the landscape of digital pathology, making diagnostic processes more efficient and accurate. As healthcare continues to evolve, key milestones highlight the potential of whole slide imaging to transform pathology practices and improve patient care.

• Increased AI Integration: Recent advancements in artificial intelligence are enhancing whole slide imaging applications, with algorithms now capable of analyzing slides for complex patterns, thereby supporting pathologists in diagnostics and improving accuracy and speed.
• Expansion of Regulatory Approvals: Regulatory bodies, such as the FDA, are increasingly approving whole slide imaging systems for clinical use. These approvals not only validate the technology's reliability but also encourage healthcare facilities to invest in digital pathology solutions.
• Advancements in Image Analysis Software: The development of sophisticated image analysis software is enabling more detailed examination of whole slide images, allowing pathologists to extract valuable insights and supporting more informed clinical decisions based on enhanced visualization.
• Growth of Remote Pathology Services: The demand for remote pathology services is on the rise, particularly following the pandemic. Whole slide imaging technology is facilitating telepathology, enabling specialists to provide consultations and diagnostics from distant locations efficiently.
• Increased Investment in Research: Significant investments in research and development by both public and private sectors are driving innovation in whole slide imaging technologies. These funds are aimed at enhancing functionality, improving interoperability, and advancing education in digital pathology.

Recent developments in the whole slide imaging market reflect a dynamic evolution in the field of pathology. With ongoing innovations and growing acceptance among healthcare professionals, whole slide imaging is set to play a pivotal role in transforming diagnostic practices and enhancing patient outcomes in the coming years.

Strategic Growth Opportunities for Whole Slide Imaging Market

The whole slide imaging market presents numerous strategic growth opportunities that can significantly enhance diagnostic practices and patient outcomes. As technology continues to advance and healthcare needs evolve, stakeholders can leverage these opportunities to expand their reach and improve services. Identifying and acting on these growth areas can lead to sustained competitive advantages in a rapidly changing landscape.

• Expanding Telepathology Services: The growing need for telepathology offers an opportunity for whole slide imaging providers to enhance remote diagnostic capabilities, particularly in underserved regions, facilitating expert consultations and improving access to quality healthcare.
• Development of AI-Driven Solutions: Investing in AI technologies can enable companies to create more advanced whole slide imaging platforms that enhance image analysis, automate diagnostic processes, and improve accuracy, thereby meeting the increasing demand for reliable diagnostic tools.
• Collaboration with Educational Institutions: Partnering with universities and research centers to develop training programs and research initiatives can foster a skilled workforce familiar with whole slide imaging technology, promoting its adoption and ensuring effective utilization in clinical practice.
• Focus on Integration with Electronic Health Records (EHR): Enhancing interoperability between whole slide imaging systems and EHRs can streamline workflows, improve data sharing, and ensure that pathologists have immediate access to patient histories, thereby enhancing the overall diagnostic process.
• Exploring Emerging Markets: Expanding operations into emerging markets presents a significant growth opportunity. As healthcare infrastructure develops in these regions, there is a rising demand for digital pathology solutions, which can be met with tailored whole slide imaging offerings.

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

Whole Slide Imaging Market Driver and Challenges

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

The factors responsible for driving the whole slide imaging market include:

• Increasing Demand for Digital Pathology: The rising need for efficient and accurate diagnostic tools is driving the adoption of WSI, as healthcare providers seek to improve patient outcomes and streamline workflow processes.
• Advancements in Technology: Continuous advancements in imaging technology, including higher resolution and better analysis software, are enhancing the capabilities of WSI systems, making them more appealing to medical institutions looking for effective solutions.
• Regulatory Approvals and Support: Growing regulatory approvals for WSI technologies from agencies like the FDA are fostering trust and encouraging healthcare providers to invest in digital pathology, thereby accelerating market growth.
• Integration of Artificial Intelligence: The integration of AI into WSI systems is revolutionizing diagnostics by enabling faster and more accurate image analysis, helping pathologists make informed decisions, and improving overall patient care.
• Expanding Telemedicine Adoption: The increased acceptance of telemedicine, particularly post-pandemic, is driving demand for telepathology solutions, making WSI an essential tool for remote consultations and enhancing access to expert care.

Challenges in the whole slide imaging market are:

• High Initial Costs: The high costs associated with implementing WSI systems can be a significant barrier for many healthcare facilities, especially smaller institutions with limited budgets, which may hinder widespread adoption.
• Data Privacy Concerns: As WSI relies on digital storage and sharing of sensitive patient information, concerns about data privacy and security can pose challenges, requiring stringent measures to protect patient confidentiality.
• Integration with Existing Systems: The complexity of integrating WSI technology with existing laboratory and hospital information systems can create operational hurdles, necessitating additional training and resources to ensure seamless functionality.

The whole slide imaging market is characterized by strong growth drivers and notable challenges. By addressing these challenges while capitalizing on the drivers, stakeholders can optimize their strategies and contribute to the successful implementation of digital pathology solutions.

List of Whole Slide Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies whole slide imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole slide imaging companies profiled in this report include-

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

Whole Slide Imaging by Segment

The study includes a forecast for the global whole slide imaging market by technology, application, end use, and region.

Whole Slide Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Whole Slide Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology
• Others

Whole Slide Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Academic Institute
• Research
• Others

Whole Slide Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Whole Slide Imaging Market

The whole slide imaging market has witnessed significant growth recently, driven by advancements in digital pathology, increasing adoption of telepathology, and rising demand for efficient diagnostic tools. This technology enhances the accuracy of pathology assessments, facilitates remote consultations, and supports educational initiatives. As the market evolves, key players are expanding their offerings and exploring innovative solutions. This report highlights recent developments in the whole slide imaging market across the United States, China, Germany, India, and Japan.

• United States: The U.S. market is rapidly expanding due to increased investments in healthcare technology and regulatory approvals, with companies focusing on enhancing AI integration to improve diagnostic accuracy and workflow efficiency.
• China: The Chinese whole slide imaging market is experiencing robust growth, fueled by government initiatives to modernize healthcare, coupled with rising demand for digital solutions among hospitals and laboratories, as well as significant investments in research and development.
• Germany: Germany is at the forefront of whole slide imaging technology in Europe, driven by strong research institutions and healthcare partnerships. Ongoing regulatory support and funding for innovative solutions are further propelling the market's expansion.
• India: The Indian whole slide imaging market is gaining momentum as healthcare facilities adopt digital pathology solutions. Increasing awareness of the benefits of whole slide imaging among pathologists and educational institutions is encouraging growth in this sector.
• Japan: Japan is leveraging its advanced technology landscape to enhance whole slide imaging applications. The government's focus on digital transformation in healthcare is fostering collaborations between tech companies and medical institutions to improve diagnostic processes.

Features of the Global Whole Slide Imaging Market

Market Size Estimates: Whole slide imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Whole slide imaging market size by technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole slide imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end uses, and regions for the whole slide imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole slide imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the whole slide imaging market by technology (scanners, IT infrastructure, viewer, and image management system), application (telepathology, cytopathology, immunohistochemistry, hematopathology, and others), end use (academic institute, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Slide Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Whole Slide Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Whole Slide Imaging Market by Technology
  • 3.3.1: Scanners
  • 3.3.2: IT Infrastructure
  • 3.3.3: Viewer
  • 3.3.4: Image Management System
• 3.4: Global Whole Slide Imaging Market by Application
  • 3.4.1: Telepathology
  • 3.4.2: Cytopathology
  • 3.4.3: Immunohistochemistry
  • 3.4.4: Hematopathology
  • 3.4.5: Others
• 3.5: Global Whole Slide Imaging Market by End Use
  • 3.5.1: Academic Institute
  • 3.5.2: Research
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Whole Slide Imaging Market by Region
• 4.2: North American Whole Slide Imaging Market
  • 4.2.1: North American Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.2.2: North American Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.3: European Whole Slide Imaging Market
  • 4.3.1: European Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.3.2: European Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.4: APAC Whole Slide Imaging Market
  • 4.4.1: APAC Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.4.2: APAC Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.5: ROW Whole Slide Imaging Market
  • 4.5.1: ROW Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.5.2: ROW Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Whole Slide Imaging Market by Technology
  • 6.1.2: Growth Opportunities for the Global Whole Slide Imaging Market by Application
  • 6.1.3: Growth Opportunities for the Global Whole Slide Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Whole Slide Imaging Market by Region
• 6.2: Emerging Trends in the Global Whole Slide Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Whole Slide Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Slide Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Olympus Corporation
• 7.2: Koninklijke Philips
• 7.3: Leica Microsystems
• 7.4: Nikon Corporation
• 7.5: Visiopharm
• 7.6: 3Dhistech
• 7.7: Hamamatsu Photonics KK
• 7.8: Indica Labs
• 7.9: Mikroscan Technologies
• 7.10: Akoya Biosciences